Qigong for pre & stage1 hypertension: a randomized trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000140

Enrollment

Registered

2011-07-05

Start date

2011-07-04

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Participans conduct qigong 5 times/week for 8 weeks. Two times per week, they conduct qigong with investigator in clinical trial center, and the other 3 times/week, they have to conduct qigon

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 19-65 years old male and female 2. pre and stage 1 hypertension based on JNC7. (SBP: 120-159mmHg. or DBP 80-99mmHg)

Exclusion criteria

Exclusion criteria: 1. patients taking prescription or OTC medication or Herb/supplement to control hypertension. 2. Secondary hypertension 3. Having cardiovascular disease. 4. Malignant tumor 5. Diabetes using insulin. 6. Having kidney or liver or thyroid disease 7. Having contagious disease 8. Getting steroid or immunosupression treatment. 9. Taking drug affect blood pressure including an oral contraceptive, neurodepressive or a stimulant.

Design outcomes

Primary

Measure	Time frame
Blood pressure	—

Secondary

Measure	Time frame
Norepinephrine, cortisol, renin, angiotensin, ANP, Total cholesterol, High Density Lipoprotein, Low Density Lipoprotein,);36-Item Short Form Health Survey Instrument ;Measure Yourself Medical Outcome Profile	—

Countries

Korea, Republic of

Contacts

Public ContactJi-Eun Park

Korea Institute of Oriental Medicine

Outcome results